ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Hypothermic Machine Perfusion Is Also Beneficial for Deceased Donor Kidneys When Cold Ischemic Time Is Short and a Short Cold Ischemic Time Is Also Beneficial When Kidneys Are Machine Perfused.

J. Kox,1 C. Moers,2 D. Monbaliu,3 A. Strelniece,4 J.-W. Treckmann,5 I. Jochmans,3 H. Leuvenink,2 L. van Heurn,1 J. Pirenne,3 A. Paul,5 R. Ploeg.2,6

1Dept. of Surgery, Maastricht University Medical Center, Maastricht, Netherlands
2Dept. of Surgery, University Medical Center Groningen, Groningen, Netherlands
3Abdominal Transplant Surgery, University Hospital Leuven, Leuven, Belgium
4Eurotransplant, Leiden, Netherlands
5General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany
6Oxford Transplant Centre, Oxford, United Kingdom.

Meeting: 2016 American Transplant Congress

Abstract number: 497

Keywords: Graft function, Ischemia, Machine preservation, Preservation

Session Information

Session Name: Concurrent Session: Ischemia Reperfusion Injury: Clinical Innovation

Session Type: Concurrent Session

Date: Tuesday, June 14, 2016

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:42pm-4:54pm

Location: Room 311

Introduction

Hypothermic machine perfusion (HMP) of deceased donor kidneys is associated with better outcome compared to static cold storage (SCS). It is generally assumed that HMP will only improve results for kidneys with a substantial degree of ischemic injury. Many transplant clinicians believe that renal grafts with a short cold ischemic time (CIT) will benefit little from HMP. Also, it is often presumed that kidneys are safe during HMP and the duration of cold ischemia is less relevant while renal grafts are on the machine. Aim of our study was to investigate whether HMP also results in a lower incidence of delayed graft function (DGF) compared to SCS for kidneys that are transplanted with a maximum of 10 hrs of cold ischemia and to test whether CIT remains an independent risk factor for DGF when kidneys are machine perfused.

Methods

We analysed data that has been prospectively collected in the Machine Preservation Trial. In this international RCT, HMP was compared to SCS of deceased donor kidneys. A total of 376 consecutive kidney donors were included, of whom one kidney was machine perfused and the other kidney was preserved by SCS. A post hoc multivariable data analysis was performed to investigate the effect of HMP versus SCS on renal grafts with a short (up to 10 hrs) CIT and to quantify the influence of CIT on the risk of DGF when kidneys are machine perfused.

Results

In this cohort, the mean CIT was 15 hrs 5 min (SD 4 hrs 58 min), the DGF incidence was 27.9%. DGF incidence in the sub group with up to 10 hrs CIT was 6.0% in the HMP arm and 28.1% in the CS arm (univariable P=0.002, multivariable OR 0.02, P=0.007). Three year graft survival in the <10 hrs CIT group did not differ significantly between study arms (88.0% for HMP and 81.2% for SCS, P=0.308). CIT remained an independent risk factor for DGF for all machine perfused kidneys recovered from DBD donors (OR =1.07, P=0.008), DCD donors (OR = 1.13, P=0.006) and ECD donors (OR = 1.14, P=0.001).

Conclusion

HMP results in lower rates of DGF than SCS in kidney transplantation. The current analysis shows that, contrary to popular belief, this is also true for renal grafts that are transplanted after a short CIT. In addition, our data suggests that CIT remains a relevant and independent risk factor for DGF in HMP-preserved kidneys.

CITATION INFORMATION: Kox J, Moers C, Monbaliu D, Strelniece A, Treckmann J.-W, Jochmans I, Leuvenink H, van Heurn L, Pirenne J, Paul A, Ploeg R. Hypothermic Machine Perfusion Is Also Beneficial for Deceased Donor Kidneys When Cold Ischemic Time Is Short and a Short Cold Ischemic Time Is Also Beneficial When Kidneys Are Machine Perfused. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Kox J, Moers C, Monbaliu D, Strelniece A, Treckmann J-W, Jochmans I, Leuvenink H, Heurn Lvan, Pirenne J, Paul A, Ploeg R. Hypothermic Machine Perfusion Is Also Beneficial for Deceased Donor Kidneys When Cold Ischemic Time Is Short and a Short Cold Ischemic Time Is Also Beneficial When Kidneys Are Machine Perfused. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/hypothermic-machine-perfusion-is-also-beneficial-for-deceased-donor-kidneys-when-cold-ischemic-time-is-short-and-a-short-cold-ischemic-time-is-also-beneficial-when-kidneys-are-machine-perfused/. Accessed May 11, 2025.

« Back to 2016 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences